People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Chimeron Bio Corp | — | Biotechnology | Series A | $15.1M | $76.6M | 2022 |
Kevin Heyeck at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin Heyeck on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Hemanshu Pandya | 1 | 3 |
| Antonin De Fougerolles | 1 | 1 |
| Monica Coleman | 1 | 1 |
| Afshin Safavi | 1 | 1 |
| Gorka Fius | 1 | 1 |
| Thimmaiah Chendrimada | 1 | 1 |
| Chiraag Patel | 1 | 1 |
| Jolly Mazmudar | 1 | 1 |
| Monica Dilip Coleman | 1 | 1 |
| Afshin Dilip Safavi | 1 | 1 |
| Chiraag Dilip Patel | 1 | 1 |
| Hemanshu Dilip Pandya | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.